SOFIE

SOFIE Biosciences is a radiopharmaceutical company focused on improving patient outcomes through the development and delivery of molecular diagnostics and therapeutics, known as theranostics. With more than 50 years of experience in PET, the company combines radiopharmaceutical research and development with production and distribution capabilities. Its network includes 14 radiopharmacy sites committed to reliable, timely delivery of products for diagnosing and treating serious illnesses. SOFIE also provides contract manufacturing services for clinical needs through its network and Theranostics Center of Excellence.

The company’s pipeline includes next-generation radiopharmaceuticals, and its work includes FAPI-based products and research. SOFIE offers access to FAPI for academic use as a diagnostic or companion diagnostic tool. To support clinical practice, it provides a PET Education Hub with evidence-based publications, case studies, and product resources intended to strengthen PET programs and patient care. Its services and resources are designed for healthcare providers, researchers, and academic partners, while product distribution serves destinations in the United States and internationally.